(+)-PD 128907 hydrochloride
(Synonyms: (+)-PD128907,盐酸盐) 目录号 : GC30848A potent D3 receptor agonist
Cas No.:300576-59-4
Sample solution is provided at 25 µL, 10mM.
(+)-PD 128907 is a potent agonist of the dopamine 3 (D3) receptor (Ki = 1 nM).1,2 It shows selectivity for D3 over D2 and D4 receptors (Kis = 1.2 and 7 ?M, respectively).1 Low doses of (+)-PD 128907 (13 ?g/kg, s.c.) reduce spontaneous locomotor activity in rats.3 It blocks stereotypy induced by the NMDA receptor antagonist (+)-MK-801 in mice.4 (+)-PD 128907 is used in animal models to study the role of the D3 receptor in nervous system disorders, such as schizophrenia, Parkinson’s disease, and depression.5,6
1.Akunne, H.C., Towers, P., Ellis, G.J., et al.Characterization of binding of [3H]PD 128907, a selective dopamine D3 receptor agonist ligand, to CHO-K1 cellsLife Sci.57(15)1401-1410(1995) 2.Pugsley, T.A., Davis, M.D., Akunne, H.C., et al.Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD 128907J. Pharmacol. Exp. Ther.275(3)1355-1366(1995) 3.Bristow, L.J., Cook, G.P., Gay, J.C., et al.The behavioural and neurochemical profile of the putative dopamine D3 receptor agonist, (+)-PD 128907, in the ratNeuropharmacology35(3)285-294(1996) 4.Witkin, J., Gasior, M., Acri, J., et al.Atypical antipsychotic-like effects of the dopamine D3 receptor agonist, (+)-PD 128,907Eur. J. Pharmacol.347(2-3)R1-R3(1998) 5.Carcinella, S., Drui, G., Boulet, S., et al.Implication of dopamine D3 receptor activation in the reversion of Parkinson's disease-related motivational deficitsTransl. Psychiatry4(6)e401(2014) 6.Gil-Mast, S., Kortagere, S., Kota, K., et al.An amino acid residue in the second extracellular loop determines the agonist-dependent tolerance property of the human D3 dopamine receptorACS Chem Neurosci.4(6)940-951(2013)
Cas No. | 300576-59-4 | SDF | |
别名 | (+)-PD128907,盐酸盐 | ||
Canonical SMILES | CCCN1[C@@]2([H])[C@@](OCC1)([H])C3=CC(O)=CC=C3OC2.Cl | ||
分子式 | C14H20ClNO3 | 分子量 | 285.77 |
溶解度 | DMSO : 150 mg/mL (524.90 mM) | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 3.4993 mL | 17.4966 mL | 34.9932 mL |
5 mM | 0.6999 mL | 3.4993 mL | 6.9986 mL |
10 mM | 0.3499 mL | 1.7497 mL | 3.4993 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.50%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet